Ivan Oransky is editor-in-chief of The Transmitter, having previously served in editorial leadership roles at outlets including Medscape, Reuters Health and Scientific American. He is a distinguished writer-in-residence at New York University’s Arthur L. Carter Journalism Institute, where he teaches medical journalism, and co-founder of Retraction Watch, which reports on scientific retractions.
![Headshot of Ivan Oransky.](https://www.thetransmitter.org/wp-content/uploads/2023/11/IvanOransky-cc.png)
Ivan Oransky
Editor-in-chief
The Transmitter
”Our goal for The Transmitter is ambitious but clear. We aspire to become an essential resource for neuroscientists at all career stages, and to help them stay current and build connections.
From this contributor
![Stack of documents marked with red sticky notes.](https://www.thetransmitter.org/wp-content/uploads/2022/04/Retraction-844.jpg)
Journal retracts paper on plant beauty that cited autism study
Education
- M.D., New York University
- B.A. in biology, Harvard University
Articles
- “Rooting out scientific misconduct” | Science
- “Retractions are increasing, but not enough” | Nature
- “Interpretation of health news items reported with or without spin: protocol for a prospective meta-analysis of 16 randomised controlled trials” | BMJ Open
- “How bibliometrics and school rankings reward unreliable science” | The BMJ
- “How to stop the unknowing citation of retracted papers” | Anesthesiology
- “Institutional research misconduct reports need more credibility” | JAMA
- “Science corrects itself, right? A scandal at Stanford says it doesn’t” | Scientific American
- “Image manipulation in science is suddenly in the news. But these cases are hardly rare” | STAT
- “Retractions in medicine: the tip of the iceberg” | European Heart Journal | Oxford Academic
- “Three randomized controlled trials evaluating the impact of ‘spin’ in health news stories reporting studies of pharmacologic treatments on patients’/caregivers’ interpretation of treatment benefit” | BMC Medicine
- “Reasonable versus unreasonable doubt” | American Scientist
Book chapters
- “Journals, peer review, and preprints,” in “A Tactical Guide to Science Journalism: Lessons From the Front Lines”
- “Retraction Watch: What we’ve learned and how metrics play a role,” in “Gaming the Metrics: Misconduct and Manipulation in Academic Research”
- “Pseudoscience, coming to a peer-reviewed journal near you,” in “Pseudoscience: The Conspiracy Against Science”
- “Will improvements in health journalism improve health literacy?” in “Volume 269: Health Literacy in Clinical Practice and Public Health”
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.